• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Real-world experience of tocilizumab in systemic sclerosis: potential benefit on lung function for anti-topoisomerase-positive patients.

作者信息

Suleman Yasir, Clark Kristina E N, Cole Alice R, Ong Voon H, Denton Christopher P

机构信息

Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital, London, UK.

出版信息

Rheumatology (Oxford). 2021 Aug 2;60(8):3945-3946. doi: 10.1093/rheumatology/keab273.

DOI:10.1093/rheumatology/keab273
PMID:33734322
Abstract
摘要

相似文献

1
Real-world experience of tocilizumab in systemic sclerosis: potential benefit on lung function for anti-topoisomerase-positive patients.托珠单抗治疗系统性硬化症的真实世界经验：对抗拓扑异构酶阳性患者肺功能的潜在益处。
Rheumatology (Oxford). 2021 Aug 2;60(8):3945-3946. doi: 10.1093/rheumatology/keab273.
2
Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti-topoisomerase I-positive systemic sclerosis-associated interstitial lung disease.利妥昔单抗治疗比环磷酰胺治疗更有效用于日本抗拓扑异构酶 I 阳性系统性硬皮病相关间质性肺病患者。
J Dermatol. 2019 Nov;46(11):1006-1013. doi: 10.1111/1346-8138.15079. Epub 2019 Sep 9.
3
Bronchoalveolar lavage in systemic sclerosis with lung involvement: role and correlations with functional, radiological and scintigraphic parameters.系统性硬皮病合并肺受累患者行支气管肺泡灌洗：作用及其与功能、影像学和闪烁扫描参数的相关性。
Rheumatol Int. 2011 Sep;31(9):1183-8. doi: 10.1007/s00296-010-1390-9. Epub 2010 Mar 30.
4
African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease.非裔美国人种族和抗拓扑异构酶I抗体与硬皮病肺病的严重程度增加有关。
Chest. 1998 Sep;114(3):801-7. doi: 10.1378/chest.114.3.801.
5
Tocilizumab plus Nintedanib for progressive interstitial lung disease in systemic sclerosis: a one-year observational study.托西利珠单抗联合尼达尼布治疗系统性硬化症进展性间质性肺病：一项为期一年的观察性研究。
Rheumatol Int. 2024 Oct;44(10):1959-1966. doi: 10.1007/s00296-024-05695-1. Epub 2024 Aug 24.
6
Tocilizumab Prevents Progression of Early Systemic Sclerosis-Associated Interstitial Lung Disease.托珠单抗预防早期系统性硬化症相关间质性肺病的进展。
Arthritis Rheumatol. 2021 Jul;73(7):1301-1310. doi: 10.1002/art.41668. Epub 2021 May 25.
7
Interstitial lung disease in systemic sclerosis.系统性硬皮病中的间质性肺疾病。
Autoimmun Rev. 2011 Mar;10(5):248-55. doi: 10.1016/j.autrev.2010.09.012. Epub 2010 Sep 21.
8
Determinants of pulmonary function improvement in patients with scleroderma and interstitial lung disease.硬皮病和间质性肺病患者肺功能改善的决定因素。
Clin Exp Rheumatol. 2007 Sep-Oct;25(5):734-9.
9
Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.血清 Krebs von den Lungen-6 水平升高与系统性硬化症：肺纤维化和疾病严重程度的标志物。
Rheumatol Int. 2018 May;38(5):813-819. doi: 10.1007/s00296-018-3987-3. Epub 2018 Feb 17.
10
Systemic sclerosis-associated interstitial lung disease treated with tocilizumab.用托珠单抗治疗的系统性硬化症相关间质性肺病
Intern Med J. 2021 Jun;51(6):999-1000. doi: 10.1111/imj.15359.

引用本文的文献

1
Single-cell analysis reveals key differences between early-stage and late-stage systemic sclerosis skin across autoantibody subgroups.单细胞分析揭示了自身抗体亚组中早期和晚期系统性硬化症皮肤之间的关键差异。
Ann Rheum Dis. 2023 Dec;82(12):1568-1579. doi: 10.1136/ard-2023-224184. Epub 2023 Aug 14.
2
Review of systemic sclerosis and antineutrophil cytoplasmic antibody vasculitis overlap: Using autoantibodies for a personalised medicine approach.系统性硬化症与抗中性粒细胞胞浆抗体血管炎重叠综合征的综述：利用自身抗体实现个性化医疗方法
J Scleroderma Relat Disord. 2023 Feb;8(1):7-13. doi: 10.1177/23971983221126850. Epub 2022 Sep 30.
3
Therapeutic Approaches to Systemic Sclerosis: Recent Approvals and Future Candidate Therapies.
系统性硬化症的治疗方法：近期获批药物和未来候选疗法。
Clin Rev Allergy Immunol. 2023 Jun;64(3):239-261. doi: 10.1007/s12016-021-08891-0. Epub 2021 Sep 1.
4
Autologous stem-cell transplantation in systemic sclerosis-associated interstitial lung disease: early action in selected patients rather than escalation therapy for all.系统性硬化症相关间质性肺病的自体干细胞移植：对部分患者采取早期干预而非对所有患者进行强化治疗。
Ther Adv Musculoskelet Dis. 2021 Aug 10;13:1759720X211035196. doi: 10.1177/1759720X211035196. eCollection 2021.
5
Systemic Sclerosis-Associated Interstitial Lung Disease: How to Incorporate Two Food and Drug Administration-Approved Therapies in Clinical Practice.系统性硬化症相关间质性肺病：如何在临床实践中纳入两种获得美国食品药品监督管理局批准的疗法。
Arthritis Rheumatol. 2022 Jan;74(1):13-27. doi: 10.1002/art.41933. Epub 2021 Nov 10.